Vitamin D supplementation in pregnant women or infants for preventing allergic diseases: a systematic review and meta-analysis of randomized controlled trials
Luo C
Published in Chinese Medical Journal
Methodology
Systematic review and meta-analysis of randomised controlled trials of maternal or infant vitamin D supplementation reporting allergic disease outcomes in offspring, with pooled risk ratios and subgroup analyses.
Key Findings
Meta-analysis of randomised trials of vitamin D given to pregnant women or infants found no significant overall reduction in asthma, wheeze, eczema/atopic dermatitis, allergic rhinitis or food allergy in offspring, although prenatal supplementation showed a borderline reduction in recurrent wheeze in early childhood in some analyses.
Conclusions
Vitamin D supplementation during pregnancy or infancy does not reliably prevent allergic disease in children, with at most a weak signal for early recurrent wheeze.
Limitations
Heterogeneous dosing regimens, timing and baseline vitamin D status across trials; outcome definitions for wheeze and eczema vary; follow-up in most trials limited to early childhood; moderate statistical heterogeneity.
Supplements Studied
Supplementation of vitamin D in pregnant women or infants does not have an effect on the primary prevention of allergic diseases.
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
National/academic research funding (China)
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.